BAM
CRL icon

Byrne Asset Management’s Charles River Laboratories CRL Stock Holding History

Byrne Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.35K Sell
28
-10
-26% -$1.78K ﹤0.01% 477
2026
Q1 		$6.55K Sell
38
-27
-42% -$5.01K ﹤0.01% 462
2025
Q4 		$13K Hold
65
– – 0.01% 397
2025
Q3 		$10.2K Sell
65
-16
-20% -$2.54K 0.01% 413
2025
Q2 		$12.3K Sell
81
-8
-9% -$1.07K 0.01% 381
2025
Q1 		$13.4K Sell
89
-17
-16% -$2.85K 0.01% 380
2024
Q4 		$19.6K Sell
106
-74
-41% -$14.3K 0.01% 299
2024
Q3 		$35.5K Sell
180
-287
-61% -$59.6K 0.02% 234
2024
Q2 		$96.8K Sell
467
-67
-13% -$15.2K 0.07% 157
2024
Q1 		$145K Buy
534
+189
+55% +$45.1K 0.1% 137
2023
Q4 		$82.4K Buy
345
+4
+1% +$787 0.06% 160
2023
Q3 		$67K Sell
341
-21
-6% -$4.31K 0.06% 172
2023
Q2 		$76K Sell
362
-11
-3% -$2.19K 0.05% 215
2023
Q1 		$75K Sell
373
-245
-40% -$55.5K 0.05% 198
2022
Q4 		$135K Sell
618
-204
-25% -$44.5K 0.1% 153
2022
Q3 		$162K Sell
822
-100
-11% -$21.6K 0.12% 124
2022
Q2 		$197K Sell
922
-192
-17% -$46.9K 0.15% 102
2022
Q1 		$316K Sell
1,114
-102
-8% -$31.5K 0.2% 93
2021
Q4 		$458K Buy
+1,216
New +$472K 0.3% 81

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Byrne Asset Management's CRL Position: Q2 2026 in Review

Byrne Asset Management reduced its Charles River Laboratories (CRL) stake by 26% in Q2 2026, selling an estimated $1.78K and leaving 28 shares worth $6.35K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Byrne Asset Management first reported a position in CRL in Q4 2021 and has held it in 19 quarters since. The position peaked at $458K in Q4 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Byrne Asset Management held 28 shares of Charles River Laboratories worth $6.35K as of Q2 2026.
  • Byrne Asset Management sold 10 Charles River Laboratories shares in Q2 2026, an estimated $1.78K.
  • Charles River Laboratories made up ﹤0.01% of Byrne Asset Management's portfolio in Q2 2026, its #477 holding.
  • Byrne Asset Management first reported a position in Charles River Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Byrne Asset Management's Charles River Laboratories position peaked at $458K in Q4 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.